XML 50 R6.htm IDEA: XBRL DOCUMENT v3.19.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities:    
Net income (loss) $ (515,043) $ 37,382
Adjustments to reconcile net income to net cash used in operating activities    
Depreciation and amortization 26,882 42,076
Interest expense on convertible debt 22,585 60,608
Loss on disposal of asset 13,581 0
Bad debt expense 0 12,558
Recognition of vesting stock option expense 0 10,967
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable (259,342) (312,645)
(Increase) decrease in inventory 70,729 216,846
(Increase) decrease in prepaid - related parties (144,587) 0
(Increase) decrease in prepaid and other assets (758,132) (38,086)
Increase (decrease) in accounts payable (217,299) 3,081
Increase (decrease) in accounts payable related parties 55,243 (60,000)
Increase (decrease) in accrued royalties and expenses 166,379 (180,220)
Increase (decrease) in accrued liabilities 299,440 209,522
Net cash flows provided by (used in) operating activities (1,239,564) 2,089
Cash flows from investing activities:    
Purchase of property and equipment (25,606) (5,749)
Cash received in reverse acquisition 508,973 0
Repurchase and cancellation of fractional shares (1,061) 0
Net cash flows from (used in) investing activities 482,306 (5,749)
Cash flows from financing activities:    
Draw on line of credit 1,000,000 0
Net cash flows used in financing activities 1,000,000 0
Net increase (decrease) in cash 242,742 (3,660)
Cash and cash equivalents, beginning of period 176,421 463,189
Cash and cash equivalents, end of period 419,163 459,529
Cash paid during the period for:    
Interest 7,465 0
Income Taxes 0 0
Supplemental non-cash investing and financing activities:    
Common stock issued for dividends on Series C Preferred Stock 0 15,007
Common stock issued for conversion of Series C Preferred Stock 0 85,561
Common stock issued for conversion of Related Party debt and interest 0 1,585,594
Common stock issued in reverse capitalization; less cash received of $508,973 $ 1,666,537 $ 0